Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease

Arthritis and Rheumatism

Volumn 65, Issue 10, 2013, Pages 2545-2554

  Willis, Van C ^a   Demoruelle, M Kristen ^a   Derber, Lezlie A ^a   Chartier Logan, Catherine J ^a   Parish, Mark C ^a   Pedraza, Isabel F ^b   Weisman, Michael H ^b   Norris, Jill M ^c   Holers, V Michael ^a   Deane, Kevin D ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c Global Health and Health Disparities   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HUMAN; LUNG; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SERODIAGNOSIS; SPUTUM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUNG; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RHEUMATOID FACTOR; RISK FACTORS; SPUTUM;

EID: 84885091835     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.38066     Document Type: Article

References (45)

1. Del Puente A, Knowler WC, Pettitt DJ, Bennett PH,. The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study. Arthritis Rheum 1988; 31: 1239-44.
2. Aho K, Palosuo T, Raunio V, Tuomi T,. The timing of rheumatoid factor seroconversions [letter]. Arthritis Rheum 1987; 30: 719-20.
3. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2741-9.
4. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50: 380-6.
5. Majka DS, Deane KD, Parrish LA, Lazar AA, Baron AE, Walker CW, et al. Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis. Ann Rheum Dis 2008; 67: 801-7.
6. Kokkonen H, Mullazehi M, Berglin E, Hallmans G, Wadell G, Ronnelid J, et al. Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis. Arthritis Res Ther 2011; 13: R13.
7. Wegner N, Wait R, Sroka A, Eick S, Nguyen KA, Lundberg K, et al. Peptidylarginine deiminase from porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum 2010; 62: 2662-72.
8. Mikuls TR, Thiele GM, Deane KD, Payne JB, O'Dell JR, Yu F, et al. Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis. Arthritis Rheum 2012; 64: 3522-30.
9. Scher JU, Ubeda C, Equinda M, Khanin R, Buischi Y, Viale A, et al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum 2012; 64: 3083-94.
10. Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, et al, for the Epidemiological Investigation of Rheumatoid Arthritis Study Group. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54: 38-46.
11. Oliver JE, Silman AJ,. Risk factors for the development of rheumatoid arthritis. Scand J Rheumatol 2006; 35: 169-74.
12. Demoruelle MK, Weisman MH, Simonian PL, Lynch DA, Sachs PB, Pedraza IF, et al. Airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum 2012; 64: 1756-61.
13. Fischer A, Solomon JJ, du Bois RM, Deane KD, Olson AL, Fernandez-Perez ER, et al. Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med 2012; 106: 1040-7.
14. Gizinski AM, Mascolo M, Loucks JL, Kervitsky A, Meehan RT, Brown KK, et al. Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA. Clin Rheumatol 2009; 28: 611-3.
15. Kips JC, Inman MD, Jayaram L, Bel EH, Parameswaran K, Pizzichini MM, et al. The use of induced sputum in clinical trials. Eur Respir J Suppl 2002; 37: 47s-50s.
16. Pavord ID, Pizzichini MM, Pizzichini E, Hargreave FE,. The use of induced sputum to investigate airway inflammation. Thorax 1997; 52: 498-501.
17. Pavord ID, Sterk PJ, Hargreave FE, Kips JC, Inman MD, Louis R, et al. Clinical applications of assessment of airway inflammation using induced sputum. Eur Respir J Suppl 2002; 37: 40s-3s.
18. Baumann U, Gocke K, Gewecke B, Freihorst J, von Specht BU,. Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study. Respir Res 2007; 8: 57.
19. Kolfenbach JR, Deane KD, Derber LA, O'Donnell C, Weisman MH, Buckner JH, et al. A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA. Arthritis Rheum 2009; 61: 1735-42.
20. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
21. Deane KD, Striebich CC, Goldstein BL, Derber LA, Parish MC, Feser ML, et al. Identification of undiagnosed inflammatory arthritis in a community health fair screen. Arthritis Rheum 2009; 61: 1642-9.
22. Hector A, Jonas F, Kappler M, Feilcke M, Hartl D, Griese M,. Novel method to process cystic fibrosis sputum for determination of oxidative state. Respiration 2010; 80: 393-400.
23. Ramsay ME, Corbel MJ, Redhead K, Ashworth LA, Begg NT,. Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine. BMJ 1991; 302: 1489-91.
24. Masson-Bessiere C, Sebbag M, Durieux JJ, Nogueira L, Vincent C, Girbal-Neuhauser E, et al. In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 2000; 119: 544-52.
25. Snir O, Widhe M, Hermansson M, von Spee C, Lindberg J, Hensen S, et al. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients. Arthritis Rheum 2010; 62: 44-52.
26. Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, Kirkham B, et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 2009; 6: e1.
27. Salvaggio JE, Waldman RH, Fruchtman MH, Wigley FM, Johnson JE III,. Systemic and secretory antibody response of atopic and non-atopic individuals in intranasally administered tetanus toxoid. Clin Allergy 1973; 3: 43-9.
28. Svard A, Kastbom A, Sommarin Y, Skogh T,. Salivary IgA antibodies to cyclic citrullinated peptides (CCP) in rheumatoid arthritis. Immunobiology 2013; 218: 232-7.
29. Dunne JV, Carson DA, Spiegelberg HL, Alspaugh MA, Vaughan JH,. IgA rheumatoid factor in the sera and saliva of patients with rheumatoid arthritis and Sjögren's syndrome. Ann Rheum Dis 1979; 38: 161-5.
30. Elkon KB, Gharavi AE, Patel BM, Hughes GR, Frankel A,. IgA and IgM rheumatoid factors in serum, saliva and other secretions: relationship to immunoglobulin ratios in systemic sicca syndrome and rheumatoid arthritis. Clin Exp Immunol 1983; 52: 75-84.
31. Otten HG, Daha MR, van der Maarl MG, Hoogendoorn LI, Beem EM, de Rooy HH, et al. IgA rheumatoid factor in mucosal fluids and serum of patients with rheumatoid arthritis: immunological aspects and clinical significance. Clin Exp Immunol 1992; 90: 256-9.
32. Harvey GP, Fitzsimmons TR, Dhamarpatni AA, Marchant C, Haynes DR, Bartold PM,. Expression of peptidylarginine deiminase-2 and -4, citrullinated proteins and anti-citrullinated protein antibodies in human gingiva. J Periodontal Res 2013; 48: 252-61.
33. Sakaida H,. IgG rheumatoid factor in rheumatoid arthritis with interstitial lung disease. Ryumachi 1995; 35: 671-7. In Japanese.
34. Martinez-Cordero E, Negrete-Garcia MC, Mendoza A,. Rheumatoid factor activity in serum and bronchoalveolar lavage fluid from patients with acute hypersensitivity pneumonitis. J Investig Allergol Clin Immunol 1992; 2: 254-7.
35. Schiotz PO, Egeskjold EM, Hoiby N, Permin H,. Autoantibodies in serum and sputum from patients with cystic fibrosis. Acta Pathol Microbiol Scand C 1979; 87: 319-24.
36. Jansen HM, Schutte AJ, Elema JD, Giessen MV, Reig RP, Leeuwen MA, et al. Local immune complexes and inflammatory response in patients with chronic interstitial pulmonary disorders associated with collagen vascular diseases. Clin Exp Immunol 1984; 56: 311-20.
37. Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD,. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006; 116: 3183-94.
38. Foo SY, Phipps S,. Regulation of inducible BALT formation and contribution to immunity and pathology. Mucosal Immunol 2010; 3: 537-44.
39. Wegner N, Lundberg K, Kinloch A, Fisher B, Malmstrom V, Feldmann M, et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 2010; 233: 34-54.
40. Twigg HL III,. Pulmonary host defenses. J Thorac Imaging 1998; 13: 221-33.
41. Makrygiannakis D, Hermansson M, Ulfgren AK, Nicholas AP, Zendman AJ, Eklund A, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008; 67: 1488-92.
42. Cerutti A, Chen K, Chorny A,. Immunoglobulin responses at the mucosal interface. Annu Rev Immunol 2011; 29: 273-93.
43. Brandtzaeg P,. Function of mucosa-associated lymphoid tissue in antibody formation [published erratum appears in Immunol Invest 2010;39:780]. Immunol Invest 2010; 39: 303-55.
44. El-Gabalawy HS, Robinson DB, Smolik I, Hart D, Elias B, Wong K, et al. Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients. Arthritis Rheum 2012; 64: 1720-9.
45. Van de Stadt LA, Witte BI, Bos WH, van Schaardenburg D,. A prediction rule for the development of arthritis in seropositive arthralgia patients. Ann Rheum Dis 2012. E-pub ahead of print.